Cleared Traditional

K854186 - IN VITRO TEST DETERMINATION OF SGPT(ALT)

K854186 is an FDA 510(k) clearance for IN VITRO TEST DETERMINATION OF SGPT(ALT), manufactured by Clinical Data, Inc.. The device is a Class 1 Chemistry device with product code CKA cleared through the Traditional 510(k) pathway after a 71-day FDA review.

K854186 · Clinical Data, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1985
Decision
71d
Days
Class 1
Risk

K854186 is an FDA 510(k) clearance for the IN VITRO TEST DETERMINATION OF SGPT(ALT). Classified as Nadh Oxidation/nad Reduction, Alt/sgpt (product code CKA), Class I - General Controls.

Submitted by Clinical Data, Inc. (Boston, US). The FDA issued a Cleared decision on December 25, 1985 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1030 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Clinical Data, Inc. devices

FDA 510(k) Submission Details - K854186

510(k) Number K854186 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 15, 1985
Decision Date December 25, 1985
Days to Decision 71 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d faster than avg
Panel avg: 88d · This submission: 71d
Pathway characteristics
Predicate-based equivalence.

CKA Device Classification - Class 1, General Controls

Product Code CKA Nadh Oxidation/nad Reduction, Alt/sgpt
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1030
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CKA Nadh Oxidation/nad Reduction, Alt/sgpt

All 116
Devices cleared under the same product code (CKA) and FDA review panel - the closest regulatory comparables to K854186.
VISION SGPT (ALT)
K861002 · Abbott Laboratories · Apr 1986
ALT(GPT) (ALANINE AMINOTRANSFERASE) REAGENT
K860727 · Trace Scientific , Ltd. · Apr 1986
GLUTAMIC PYRUVIC TRANSAMINASE, GPT(UV) REAGENT SET
K860110 · Technostics Intl. · Feb 1986
ALT(OPTIMIZED) REAGENT
K854502 · Sigma Diagnostics, Inc. · Nov 1985
HI-CHEM DIAGNOSTICS ENZYME RINSE CONCENTRATE
K852867 · Hi Chem, Inc. · Aug 1985
ALT (ALANINE AMINO-THRANSFERASE)REAGENT
K851995 · Alpkem Corp. · May 1985